Related Experiment Video
Updated: Jul 15, 2026
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
[Preparation and characterization of monoclonal antibody against CP4-EPSPS]
Ling-xia Jing1, Xue-fei Cai, Sheng-zhi Mu
1The Institute for Viral Hepatitis, Key Laboratory of Molecular Biology on Infectious Disease, Chongqing University of Medical Sciences, Chongqing 400016, China. jinglxcm@163.com
Aim:
To prepare monoclonal antibody (mAb) against CP4-EPSPS, which could be applied to the development of gold colloidal rapid diagnostic kit for the specific detection of GMO.
Methods:
BALB/c mice were immunized with CP4-EPSPS. Splenocytes of the immunized mice were collected and fused with the mouse myeloma cell line Sp2/0 cells. The hybridoma cells that secreted CP4-EPSPS mAb antibodies were cloned with limited dilution method. The immunoglobulin (Ig) subtype, the ascites titers, the binding site, and the affinity of the obtained mAbs were determined by indirect ELISA. The specificity of mAbs was tested by ELISA and Western blot analysis.
Results:
From over 80 positive hybridomas which secreted anti-cp4-EPSPS mAbs, a pair of hybridomas were screened out, designated III5A3 and III13A2. Chromosome analysis revealed that the obtained hybridomas were with the universal characteristics of the monoclonal hybridoma cells which secreted mAb, and the Ig subtype of III5A3 and III13A2 mAb was both IgG1. The ascites titers of III5A3 and III13A2 mAb were 1:10(6) and 1:10(8), respectively. Our study also demonstrated that these two mAbs, which recognized the same epitope, could both specifically bind to the CP4-EPSPS protein. The relative affinity constant of III5A3 and III13A2 mAb was determined as 10(5) and 10(6) respectively.
Conclusion:
A pair of high titer, specific mAbs against CP4-EPSPS have been successfully prepared and primarily identified, which may be useful in the development of a rapid and convenient diagnostic kit for detection of GMO.
